Annovis Research Development from 2010 to 2026

ANVS Stock  USD 2.49  0.09  3.49%   
Annovis Bio Research Development yearly trend continues to be comparatively stable with very little volatility. Research Development will likely drop to about 12.1 M in 2026. From the period from 2010 to 2026, Annovis Bio Research Development quarterly data regression had r-value of  0.73 and coefficient of variation of  152.64. View All Fundamentals
 
Research Development  
First Reported
2012-12-31
Previous Quarter
5.2 M
Current Value
6.3 M
Quarterly Volatility
3.4 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Annovis Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Annovis Bio's main balance sheet or income statement drivers, such as Interest Expense of 2 M, Selling General Administrative of 8.1 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 6.22. Annovis financial statements analysis is a perfect complement when working with Annovis Bio Valuation or Volatility modules.
  
Build AI portfolio with Annovis Stock
Check out the analysis of Annovis Bio Correlation against competitors.
For more information on how to buy Annovis Stock please use our How to Invest in Annovis Bio guide.
The evolution of Research Development for Annovis Bio provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Annovis Bio compares to historical norms and industry peers.

Latest Annovis Bio's Research Development Growth Pattern

Below is the plot of the Research Development of Annovis Bio over the last few years. It is Annovis Bio's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Annovis Bio's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Annovis Research Development Regression Statistics

Arithmetic Mean7,353,184
Geometric Mean1,383,543
Coefficient Of Variation152.64
Mean Deviation8,794,844
Median273,370
Standard Deviation11,224,235
Sample Variance126T
Range38.7M
R-Value0.73
Mean Square Error63.2T
R-Squared0.53
Significance0.0009
Slope1,618,209
Total Sum of Squares2015.7T

Annovis Research Development History

202612.1 M
202523 M
202420 M
202338.8 M
202216.5 M
20218.5 M
20203.1 M

About Annovis Bio Financial Statements

Annovis Bio shareholders use historical fundamental indicators, such as Research Development, to determine how well the company is positioned to perform in the future. Although Annovis Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Annovis Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Annovis Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Research Development23 M12.1 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Annovis Stock Analysis

When running Annovis Bio's price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.